Showing results (111-120 of 123) with videos related to

Sort By:
Pageof 13
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|June 18, 2022
Prescription patterns of pancreatic enzyme replacement therapy for patients with pancreatic cancer in the United StatesTejeshwar Jain, Prateek Sharma, Bhuwan Giri, et al.
Cancer Immunology Research|April 17, 2020
Vaccination against Nonmutated Neoantigens Induced in Recurrent and Future TumorsGreta Garrido, Brett Schrand, Agata Levay, et al.
Gastroenterology|June 18, 2018
NFκB in Pancreatic Stellate Cells Reduces Infiltration of Tumors by Cytotoxic T Cells and Killing of Cancer Cells, via Up-regulation of CXCL12Bharti Garg, Bhuwan Giri, Shrey Modi, et al.
Gastroenterology|April 10, 2018
Gut Microbiota Promotes Tumor Growth in Mice by Modulating Immune ResponseVrishketan Sethi, Saba Kurtom, Mohammad Tarique, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|April 28, 2019
Evolution of surgical management of gallbladder carcinoma and impact on outcome: results from two decades at a single-institutionJohn M Creasy, Debra A Goldman, Mithat Gonen, et al.
Oncoimmunology|September 23, 2021
Hsp70 modulates immune response in pancreatic cancer through dendritic cellsBhuwan Giri, Prateek Sharma, Tejeshwar Jain, et al.
JCI Insight|November 30, 2021
Pirfenidone increases IL-10 and improves acute pancreatitis in multiple clinically relevant murine modelsEjas Palathingal Bava, John George, Mohammad Tarique, et al.
Arquivos Brasileiros De Cirurgia Digestiva : ABCD = Brazilian Archives of Digestive Surgery|November 12, 2025
Global strategies for the diffusion of robotic surgeryFrancisco Tustumi, Louisa Bolm, Rodrigo Camargo Leão Edelmuth, et al.
Iscience|March 19, 2025
Smoking-induced gut microbial dysbiosis mediates cancer progression through modulation of anti-tumor immune responsePrateek Sharma, Tejeshwar Jain, Ali Sorgen, et al.
Annals of Surgery|July 9, 2019
Survival Outcomes Associated With Clinical and Pathological Response Following Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Chemotherapy in Resected Pancreatic CancerFrancis I Macedo, Emily Ryon, Shishir K Maithel, et al.
Pageof 13